Spontaneous splicing mutations at the dihydrofolate reductase locus in Chinese hamster ovary cells.

We isolated and characterized three spontaneous mutants of Chinese hamster ovary cells that were deficient in dihydrofolate reductase activity. All three mutants contained no detectable enzyme activity and produced dihydrofolate reductase mRNA species that were shorter than those of the wild type by about 120 bases. Six exons are normally represented in this mRNA; exon 5 was missing in all three mutant mRNAs. Nuclease S1 analysis of the three mutants indicated that during the processing of the mutant RNA, exon 4 was spliced to exon 6. The three mutant genes were cloned, and the regions around exons 4 and 5 were sequenced. In one mutant, the GT dinucleotide at the 5' end of intron 5 had changed to CT. In a second mutant, the first base in exon 5 had changed from G to T. In a revertant of this mutant, this base was further mutated to A, a return to a purine. Approximately 25% of the mRNA molecules in the revertant were spliced correctly to produce an enzyme with one presumed amino acid change. In the third mutant, the AG at the 3' end of intron 4 had changed to AA. A mutation that partially reversed the mutant phenotype had changed the dinucleotide at the 5' end of intron 4 from GT to AT. The splicing pattern in this revertant was consistent with the use of cryptic donor and acceptor splice sites close to the original sites to produce an mRNA with three base changes and a protein with two amino acid changes. These mutations argue against a scanning model for the selection of splice site pairs and suggest that only a single splice site need be inactivated to bring about efficient exon skipping (a regulatory mechanism for some genes). The fact that all three mutants analyzed exhibited exon 5 splicing mutations indicates that these splice sites are hot spots for spontaneous mutation.     

Molecular diagnosis of Menkes disease: Genotype–phenotype correlation

Menkes syndrome is an X-linked, fatal neurodegenerative disorder of copper metabolism, caused by mutations in the ATP7A gene, encoding a copper-transporting P1B-type ATPase. To date, a total of approximately 160 different mutations have been reported worldwide. The clinical phenotypes observed in these patients include progressive neuro-degeneration, connective-tissue abnormalities and peculiar hair. There is phenotypic variability. While the majority of the patients do not survive early childhood, milder cases leading to longer survival have been reported. In this review we focus on mutations, identified in patients with milder forms of Menkes disease, and discuss the possibility of establishing a genotype–phenotype correlation. The presence of small amounts of normal protein, or the presence of partly functional protein variants containing a less essential amino acid substitution or a truncation of the N- or C-terminus, might all result in a milder, atypical phenotype. A clear phenotype–genotype correlation is however difficult to establish, clearly illustrated by the presence of inter- and even intra-familial variability.     

利用RT-PCR技术验证基于小鼠外显子芯片发现的缺血相关基因的表达

目的:利用RT-PCR技术验证并确认基于小鼠外显子芯片发现的部分缺血相关基因的表达,以鉴定候选基因的外显子是否发生可变剪接,从而实现对外显子芯片结果的鉴定。方法:根据生物信息学分析结果,选取小鼠外显子芯片中的3个基因(Ube3c,6330439K17Rik,Atp7a),在预测发生可变剪接的外显子两侧设计上下游引物,PCR后进行凝胶回收,再克隆到载体中进行测序。结果:RT-PCR及测序结果表明,Ube3c基因在6号外显子、6330439K17Rik基因在12号外显子、Atp7a基因在3号外显子发生可变剪接,与芯片预测结果一致。结论:RT-PCR技术可针对外显子芯片的结果进行可靠性验证,为可变剪接基因表达研究提供了一种有效手段。     

Response heterogeneity of human macrophages to ATP is associated with P2X7 receptor expression but not to polymorphisms in the P2RX7 promoter

A region 2 kb upstream of exon 1 of the P2X7 gene was sequenced using DNA from nine healthy individuals who exhibited three different ATP response phenotypes (i.e. high, low and interferon gamma-inducible). Five single nucleotide polymorphisms were identified within the nine donor promoter sequences but none were associated with a specific ATP response phenotype. A P2X7 loss of function polymorphism (1513 in exon 13) was also screened for within donor DNA but no response associations were identified. ATP response phenotype was positively associated with P2X(7) receptor expression, as assessed by flow cytometry, but not with any identified receptor or promoter gene polymorphisms.     

High incidence of later-onset fabry disease revealed by newborn screening

The classic phenotype of Fabry disease, X-linked alpha -galactosidase A (alpha -Gal A) deficiency, has an estimated incidence of approximately 1 in 50,000 males. The recent recognition of later-onset variants suggested that this treatable lysosomal disease is more frequent. To determine the disease incidence, we undertook newborn screening by assaying the alpha-Gal A activity in blood spots from 37,104 consecutive Italian male neonates. Enzyme-deficient infants were retested, and "doubly screened-positive" infants and their relatives were diagnostically confirmed by enzyme and mutation analyses. Twelve (0.03%) neonates had deficient alpha-Gal A activities and specific mutations, including four novel missense mutations (M51I, E66G, A73V, and R118C), three missense mutations (F113L, A143T, and N215S) identified previously in later-onset patients, and one splicing defect (IVS5(+1G-->T)) reported in a patient with the classic phenotype. Molecular modeling and in vitro overexpression of the missense mutations demonstrated structures and residual activities, which were rescued/enhanced by an alpha-Gal A-specific pharmacologic chaperone, consistent with mutations that cause the later-onset phenotype. Family studies revealed undiagnosed Fabry disease in affected individuals. In this population, the incidence of alpha-Gal A deficiency was 1 in approximately 3,100, with an 11 : 1 ratio of patients with the later-onset : classic phenotypes. If only known disease-causing mutations were included, the incidence would be 1 in approximately 4,600, with a 7 : 1 ratio of patients with the later-onset : classic phenotypes. These results suggest that the later-onset phenotype of Fabry disease is underdiagnosed among males with cardiac, cerebrovascular, and/or renal disease. Recognition of these patients would permit family screening and earlier therapeutic intervention. However, the higher incidence of the later-onset phenotype in patients raises ethical issues related to when screening should be performed--in the neonatal period or at early maturity, perhaps in conjunction with screening for other treatable adult-onset disorders.     

X-连锁迟发性脊椎骨骺发育不良基因剪接受体突变对mRNA加工的影响

X-连锁迟发性脊椎骨骺发育不良（spondyloepiphyseal dysplasia tarda, SEDL）是一种少见的由SEDL基因突变引起的骨软骨发育障碍性疾病,病变主要累及腰椎和近端承重大关节。为研究SEDL基因剪接受体突变(IVS2 -2A→C)对mRNA加工的影响,从该突变所致SEDL患者,以及健康对照者外周血中提取总RNA,逆转录合成cDNA, 以此为模板进行聚合酶链式反应（polymerase chain reaction, PCR）,对PCR扩增产物采用双向直接测序和非变性聚丙烯酰胺凝胶电泳(polyacrylamide gel electrophoresis, PAGE)方法进行分析。测序结果发现IVS2-2A→C突变患者的一种cDNA外显子2与外显子4直接拼接,显示外显子3全部丢失;另一种cDNA外显子1与外显子4拼接,显示外显子2和外显子3均缺失;在健康对照者也发现了外显子2缺失的cDNA。PAGE发现患者和对照者都存在两种RT-PCR产物,长度分别为567bp、425bp以及679bp、537bp,证实了测序结果。这说明SEDL基因第二内含子剪接受体突变（IVS2-2A→C）导致其外显子3在mRNA加工过程中全部丢失,由于SEDL基因的翻译起始位点位于外显子3,它的缺失可能使生成的mRNA不能被翻译,从而引起SEDL发生;外显子2位于5′ UTR,它的缺失提示SEDL基因存在选择性剪接,正常人也存在缺失外显子2的cDNA,说明这种选择性剪接对临床表型的影响似乎并不大,它对基因表达水平和表达调控是否有影响还需要进一步研究。